Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
116 studies found for:    Open Studies | "Niacin"
Show Display Options
Rank Status Study
21 Not yet recruiting Effect of "Nicotinamide Mononucleotide" (NMN) on Cardiometabolic Function
Condition: Glucose Metabolism Disorders
Interventions: Dietary Supplement: NMN supplement;   Other: Placebo
22 Not yet recruiting Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
Conditions: Multiple Myeloma;   Non-Hodgkin Lymphoma;   Diffuse Large B Cell Lymphoma;   Mantle-Cell Lymphoma;   Follicular Lymphoma;   Indolent B Cell Lymphoma;   Primary Mediastinal Lymphoma;   Lymphoplasmacytic Lymphoma
Intervention: Biological: Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
23 Not yet recruiting Investigation of the Cosmetic Benefit Provided by Regular Application of a Moisturising Cream in People With Blemish Prone Skin
Condition: Skin Care
Interventions: Other: Washout / Standard Cleanser;   Other: Test product;   Other: Positive control cleanser;   Other: Positive control moisturiser
24 Not yet recruiting Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
Condition: Dyslipoproteinemias
Interventions: Drug: PCSK9 Inhibitor [EPC];   Drug: Standard lipid lowering therapy
25 Recruiting Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Conditions: Obesity;   Rhinitis;   Rhinitis, Allergic;   Respiratory Sounds;   Dyspnea;   Headache;   Migraine Disorders;   Arthritis;   Arthralgia;   Anxiety;   Sleep Initiation and Maintenance Disorders;   Sleep Deprivation
Interventions: Dietary Supplement: Vitamin A;   Dietary Supplement: Vitamin B6;   Dietary Supplement: Vitamin C;   Dietary Supplement: Nicotinamide;   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin E;   Other: Broccoli;   Other: Spinach;   Dietary Supplement: Caffeine;   Other: Coffee;   Device: Axon Eyewear;   Other: Chocolate
26 Recruiting Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
Condition: Congenital Heart Disease
Interventions: Dietary Supplement: Vitamin B Complex and Folic Acid;   Dietary Supplement: Iron and Folic Acid;   Dietary Supplement: Folic Acid
27 Recruiting Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.
Conditions: Hepatocellular Carcinoma;   Perfusion Scanner
Intervention: Other: Scannographic evaluation of the tumor response performed with mRECIST criteria after 3 months of treatment with sorafenib
28 Recruiting Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma
Condition: HCC
Interventions: Procedure: RFA;   Drug: Sorafenib
29 Not yet recruiting Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis
Conditions: HepatoCellular Carcinoma;   Portal Vein Thrombosis
Interventions: Procedure: HAIC;   Drug: Sorafenib
30 Recruiting Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients
Condition: Hepatocellular Carcinoma
Interventions: Drug: PDR001;   Drug: Sorafenib
31 Recruiting Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients.
Condition: HCC
Interventions: Drug: Sorafenib;   Drug: Best Supportive care
32 Recruiting Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection
Conditions: Hepatocellular Carcinoma;   Recurrence
Intervention: Drug: Sorafenib
33 Recruiting Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC)
Intervention: Biological: Sorafenib plasma concentration 4 weeks after treatment initiation
34 Recruiting TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer
Condition: Carcinoma, Hepatocellular
Interventions: Radiation: SBRT;   Procedure: TACE;   Drug: Sorafenib
35 Recruiting Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Sorafenib
36 Recruiting Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma
Condition: HCC
Interventions: Drug: Donafenib;   Drug: Sorafenib
37 Recruiting Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients
Condition: Hepatocellular Carcinoma
Interventions: Drug: Enzalutamide;   Drug: Enzalutamide with Sorafenib
38 Recruiting Sorafenib Administered Using a High-dose, Pulsatile Regimen: a Phase I Exposure Escalation Study
Condition: Neoplasms
Intervention: Drug: sorafenib
39 Recruiting A Study to Compare Tivozanib Hydrochloride to Sorafenib in Subjects With Refractory Advanced RCC
Condition: Carcinoma, Renal Cell
Interventions: Drug: tivozanib hydrochloride;   Drug: Sorafenib
40 Recruiting Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Interventions: Drug: Imetelstat;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.